feed,title,long_url,short_url
Investors,CorMedix Spikes To Four-Year High On A Surprise Deal For Its Leading Drug,https://www.investors.com/news/technology/cormedix-stock-defencath-large-dialysis-organization/,
Investors,Amgen Expands Development Plans For Highly Anticipated Obesity Drug,https://www.investors.com/news/technology/amgen-obesity-drug-maritide-eli-lilly-zepbound/,
